FDA NDC Directory · JSON-LD · Markdown

Rivastigmine Tartrate

NDC 55111-352 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerDr. Reddy's Laboratories Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA077130
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIVASTIGMINE TARTRATE (1.5 mg/1)
Marketing started20110901
Package count4

External sources

Source: openFDA. Public-domain (CC0).